October 19, 2015
Rapid Micro Biosystems Announces the Commercial Availability of The Growth Direct™ System for Sterility Testing

October 14, 2015
Rapid Micro Biosystems Announces New Vice President of Sales

October 14, 2015
Calhoun Vision Named One of the "Fierce 15" Med Tech Companies of 2015 by FierceMedicalDevices

October 13, 2015
Preliminary Third Quarter 2015 Revenue Results in Advance of Attendance at the 30th Annual North American Spine Society (Nass) Meeting in Chicago, Illinois

October 12, 2015
AlphatecSpine Introduces New Titanium-Coated PEEK Interbody Fusion System

October 12, 2015
Collegium Provides Update on FDA Review of Xtampza(TM) ER, an Abuse-Deterrent Analgesic for the Treatment of Chronic Pain

October 9, 2015
Aimmune Therapeutics Announces COO Transition

October 7, 2015
Aimmune Therapeutics Receives EMA Decision Agreeing With PIP for AR101 for the Treatment of Peanut Allergy

October 2, 2015
Medtronic Completes Acquisition of Twelve, Inc.

October 1, 2015
Alphatec Spine Launches Alphatec Neocore(TM) Osteoconductive Matrix in the U.S.

September 30, 2015
Jazz Pharmaceuticals Announces U.S. FDA Acceptance for Filing with Priority Review of NDA for Defibrotide for Hepatic Veno-Occlusive Disease

September 28, 2015
CardioDx Announces Positive Data from a Large Primary Care Registry on the Impact of the Corus CAD Test in the Assessment of Obstructive Coronary Artery Disease in Women

September 28, 2015
Corcept Therapeutics Appoints Robert S. Fishman, M.D., as Chief Medical Officer

September 28, 2105
Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes

September 24, 2015
Alphatec's Less-Invasive Arsenal™ Cortical Bone Fixation System Successfully Used in Over 50 Patients

September 17, 2015:
Alphatec's Arsenal™ Spinal Fixation System Further Expanded to Address Broader Market

September 16, 2015
CardioDx Expands Patient Access to the Corus® CAD Test through National Agreement with Quest Diagnostics

September 11, 2015
Collegium Announces FDA Advisory Committees Unanimously Recommend Approval of Xtampza ER(TM), an Abuse-Deterrent Analgesic for Chronic Pain

September 8, 2015
Alphaeon Launches ShoutMD 3.0, the First Social Commerce Store for Lifestyle Healthcare Products

September 3, 2015:
Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering

September 1, 2015
Rapid Micro Biosystems announces the commercial availability of The Growth Direct™ MultiTest System

August 31, 2015
Aimmune Therapeutics Reports Second Quarter 2015 Financial Results

August 25, 2015
Medtronic to Acquire Twelve, Inc., Developer of Transcatheter Mitral Valve Replacement Device

August 24, 2015
Practice Fusion Surpasses 600th Partnership Deal Becoming the Most Integrated Cloud-Based EHR Platform

August 19, 2015
Orbus Therapeutics Secures $32.5 Million Series A Financing to Advance Late-Stage Brain Cancer Drug

August 17, 2015:
Esperion Therapeutics Provides Update on the ETC-1002 Development Program Following End-of-Phase 2 Meeting With FDA

August 14, 2015:
Practice Fusion Announces CEO Transition

August 12, 2015
Collegium Reports Second Quarter Financial Results and Provides Corporate Update

August 11, 2015
Aimmune Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

August 11, 2015
Rapid Micro Biosystems Expands Series C Round With Investment From EDBI

August 7, 2015
Collegium Announces FDA Advisory Committee Meeting for Xtampza(TM) ER, an Abuse-Deterrent Analgesic for Chronic Pain

August 6, 2015
Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Second Quarter 2015 Financial Results

August 5, 2015
Corcept Therapeutics Announces Second Quarter 2015 Results and Provides Corporate Update

August 5, 2015
Aimmune Therapeutics Announces Pricing of Initial Public Offering

August 5, 2015
Jazz Pharmaceuticals Announces Second Quarter 2015 Financial Results

August 4, 2015:
Alphatec Holdings Announces Second Quarter 2015 Revenue and Financial Results

August 4, 2015
Calhoun Vision Elects Former SEC Chairman and Congressional Leader Chris Cox to Board of Directors

July 30, 2015
Practice Fusion Expands Leadership Team and Board with Industry Veterans from Google, Amazon, WebMD, Quest Diagnostics, and Zendesk

July 29, 2015
Esperion Therapeutics to Provide Second Quarter Program Updates and Financial Results

July 28, 2015
Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

July 23, 2015
SutroVax raises $22 million in Series A

July 17, 2015
Esperion Therapeutics Announces Removal of 240 mg Partial Clinical Hold for ETC-1002

July 8, 2015
Rapid Micro Biosystems Completes $19 Million Senior Credit Facilities

July 6, 2015
Aimmune Therapeutics Files Registration Statement for Initial Public Offering

July 1, 2015
Collegium Expands Leadership Team With Vice President of Regulatory Affairs and Quality Assurance

June 22, 2015
Corcept Therapeutics Appoints Daniel Swisher to Board of Directors

June 19, 2015
Medtronic Acquires Aptus Endosystems

June 18, 2015
Aimmune Therapeutics Receives FDA Breakthrough Therapy Designation for AR101

June 18, 2015
Calhoun Vision Expands Executive Team With Proven Ophthalmic Industry Veterans

June 18, 2015
Practice Fusion is the Market Share Leader for Solo and Small Clinician Practices

June 15, 2015
Esperion Therapeutics Announces the Appointment of Scott Braunstein, M.D. to Board of Directors

June 8, 2015
Collegium Announces Issuance of U.S. Patent Covering DETERx(R) - an Abuse-Deterrent, Extended-Release Technology Platform

June 7, 2015
Aimmune Therapeutics Announces Positive Phase 2 Study Results of AR101 for the Treatment of Peanut Allergy

June 4, 2015
Calhoun Vision Raises $69 Million in Financing

June 1, 2015
Collegium Expands Commercial Organization With Key Appointments

May 27, 2015
Allergen Research Corporation Renamed Aimmune Therapeutics

May 20, 2015
Venus Viva™ receives FDA clearance for dermatological procedures requiring ablation and resurfacing of the skin

May 19, 2015
Practice Fusion and the American Urological Association Collaborate to Launch Overactive Bladder Population Health Management Initiative

May 18, 2015
Allergen Research Corporation Names Mark McDade as Chairman and Mark Iwicki as Member of the Board of Directors

May 18, 2015
Prospective Patient Registry Demonstrates the Corus CAD Test Score Impacts Real-World Clinical Decision-Making in Patients Presenting with Symptoms Suggestive of Obstructive Coronary Artery Disease

May 18, 2015
Encore Dermatology, Inc., A New Specialty Dermatology Company

May 13, 2015
Corcept Therapeutics' Mifepristone Combined with Eribulin to Improve Antitumor Activity in Patients with Triple-Negative Breast Cancer

May 7, 2015
Collegium Pharmaceutical Announces Pricing of Its Initial Public Offering

May 6, 2015 
ALPHAEON Appoints Hon. Christopher Cox and Dennis Wolf to Board of Directors

May 1, 2015
Alphatec Spine Announces Appointment of Donald A. Williams to its Board of Directors

May 6, 2015
Rapid Micro Biosystems Announces New Chief Financial Officer

April 29, 2015
Rapid Micro Biosystems Secures $25 Million in Series C Equity Financing

April 29, 2015
Stealth Foundry Grad Twelve Racks Up $35M for Percutaneous Mitral Valve Replacement

April 21, 2015
Allergen Research Corporation Announces New CFO Warren DeSouza and Board of Directors Audit Committee Chair Kate Falberg

April 17, 2015
PRN's Omega-3 Hits Major Endpoints Against Placebo in a Study of Dry Eye Symptoms

April 16, 2015
ALPHAEON Expands ALPHAEONMD Practice System with Launch of ENGAGEMD

April 14, 2015
Practice Fusion and ePatientFinder Partner to Launch One of the Nation’s Largest EHR-Based Clinical Trial Networks

April 13, 2015
Practice Fusion and AstraZeneca Partner on Population Health Management Initiative for Asthma and Chronic Obstructive Pulmonary Disease

April 8, 2015
Allergen Research Corporation Expands Management with New VP Functions

April 1, 2015
Warrant Exercises Generate $17.2 Million; Proceeds to Advance Next-Generation Compounds and Support Commercialization of Korlym.

April 1, 2015
CardioDx Announces Positive Results from Clinical Utility Study Evaluating the Corus CAD Blood Test's Influence on Clincial Decision Making in the Assessment of Obstructive Coronary Artery Disease in Women

March 24, 2015
Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock.

March 12, 2015
Allergen Research Corporation Completes $80 Million Series B Financing to Advance Drug Development Portfolio for Food Allergy

March 10, 2015
Collegium Raises $50 Million Financing to Support Commercial Development of its Lead Abuse-Deterrent Product Candidate.

March 6, 2015
Amarin Announces $52.8 Million Private Placement

March 4, 2015
Corcept Recorded Net Revenue of 9.0 Million in the Fourth Quarter of 2014, Compared to $4.1 Million for the Same Period in 2013. The Company Estimates 2015 Net Revenue Will Be Between $47 Million and $53 Million.

February 26, 2015
Collegium Pharmaceutical Announces Notice of Allowance for U.S. Patent Covering DETERx, and Abuse-Deterrent Analgesic for Chronic Pain

February 17, 2015
CoverMyMeds and Practice Fusion Partner to Bring Electronic Prior Authorizations for Medications to Over 110,000 of Practice Fusion’s Users

February 15, 2015
Healthy Women and the National Association of Nurse Practitioners in Women's Health are Partnering with CardioDx on a New Patient Advocacy Campaign to Empower Women to be Proactive in Discussing Their Heart Health and Testing Options with Their Healthcare Providers. It's Called Spread the Word.

February 9, 2015
Collegium Pharmaceutical Appoints Chief Financial Officer and New Member to its Board of Directors.

January 15, 2015
ALPHAEON Corporation Closes Series A Preferred Stock Financing In A Transaction Led By Longitude Capital Management Co., LLC.

January 14, 2015
Flamel Sinks on Jazz Pharma Patent Ruling

© 2015 Longitude Capital Management Co., LLC. All rights reserved.